Majority of patients responded in CAR T-cell trial for mantle cell lymphoma
Study showed 93% of patients responded with 67% achieving complete response A one-year follow-up study…
Browsing: mantle cell lymphoma
New drug effective in overcoming ibrutinib resistance in mantle cell lymphoma
A study at The University of Texas MD Anderson Cancer Center demonstrated how a small…
New drugs are improving survival times for patients with aggressive type of blood cancer
Survival times for a highly aggressive type of blood cancer have nearly doubled over the…